EHRA Premium Access

Prevention of early sudden cardiac death after myocardial infarction using the wearable cardioverter defibrillator - results from a real-life cohort

Presentation

About the speaker

Doctor Ursula Rohrer

Medical University of Graz, Graz (Austria)
0 follower

6 more presentations in this session

Device-detected sleep-disordered breathing predicts implantable defibrillator therapy in patients with heart failure

Speaker: Doctor A. Mazza (Orvieto, IT)

Thumbnail

Implantable cardioverter-defibrillator therapy in the very young - Patient characteristics procedural outcome and one-year follow-up - A subgroup analysis of the german DEVICE registry

Speaker: Doctor D. Chung (Hamburg, DE)

Thumbnail

Age-related differences and associated outcomes of S-ICD: insights from a large, european, multicenter, real-world registry

Speaker: Doctor M. Schiavone (Milan, IT)

Thumbnail

Real-world survival of model-3501 subcutaneous implantable defibrillator lead

Speaker: Doctor F. Migliore (Padova, IT)

Thumbnail

Procedure related complications following implantation of cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillator (ICD) devices - Insights from the German DEVICE registry

Speaker: Doctor L. Kaiser (Hamburg, DE)

Thumbnail

Access the full session

Moderated ePosters - Variety of news on device therapy

Speakers: Doctor U. Rohrer, Doctor A. Mazza, Doctor D. Chung, Doctor M. Schiavone, Doctor F. Migliore...
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Related content

EHRA Premium Access

Left ventricular septal pacing: how deep is enough?

5 April 2022

This platform is supported by

logo Novo Nordisk